RequiredCanagliflozin 100 mg – Quick Overview
Canagliflozin 100 mg is a prescription medication used to lower blood sugar in adults with type 2 diabetes and to reduce cardiovascular and kidney risks in certain patients. It works by causing the kidneys to remove excess sugar from the body through urine. It is taken once daily, exactly as prescribed and monitored by your doctor.
Medical Supervision & Regulatory Status
Canagliflozin 100 mg is available only by prescription in the United States and is regulated by the FDA. Because it affects kidney function, fluid balance, and blood sugar control, ongoing medical supervision is required to monitor for side effects and adjust dosing safely.
Clinical Context
Type 2 diabetes occurs when the body doesn't use insulin effectively, leading to consistently high blood sugar levels that can damage blood vessels, nerves, kidneys, and the heart over time. Left uncontrolled, it significantly raises the risk of heart disease, stroke, kidney failure, and other complications.
Diet, exercise, and first-line medications like metformin aren't always enough to bring blood sugar into target range for every patient, especially those with additional cardiovascular or kidney risk factors. Canagliflozin offers an alternative mechanism of blood sugar control that also provides measurable heart and kidney protective benefits in certain patients.
Canagliflozin belongs to the SGLT2 inhibitor class and is typically used in combination with diet, exercise, and sometimes other diabetes medications, as part of an individualized treatment plan directed by a physician.
How Canagliflozin Works
Canagliflozin belongs to the sodium-glucose cotransporter-2 (SGLT2) inhibitor drug class. It lowers blood sugar by blocking SGLT2 proteins in the kidneys, causing excess glucose to be removed from the body through urine rather than being reabsorbed into the bloodstream.
Because this mechanism works independently of insulin, canagliflozin can be used alone or alongside other diabetes medications. Beyond blood sugar control, clinical studies have shown additional heart and kidney benefits: in 2018 canagliflozin was approved to reduce major heart-related events, and in 2019 it was approved to reduce risk of end-stage kidney disease, worsening kidney function, heart-related death, and heart failure hospitalization in appropriate patients.
By lowering blood sugar and supporting cardiovascular and kidney health, canagliflozin may help reduce the long-term complications associated with poorly controlled type 2 diabetes when used consistently as prescribed.
What is Canagliflozin?
Drug Class: SGLT2 inhibitor (sodium-glucose cotransporter-2 inhibitor)
Active Ingredient: Canagliflozin
Mechanism: Blocks glucose reabsorption in the kidneys, causing excess sugar to leave the body through urine
Form: Oral tablet, 100 mg
Dosing Frequency: Once daily, typically before the first meal of the day
Regulatory Status: Prescription-only in the U.S., FDA-approved
Uses / Indications
Type 2 Diabetes: Used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
Cardiovascular Risk Reduction: Approved to reduce the risk of major heart-related events such as heart attack, stroke, or cardiovascular death in adults with type 2 diabetes and known heart disease.
Kidney Protection: Approved to reduce the risk of end-stage kidney disease, worsening kidney function, cardiovascular death, and heart failure hospitalization in patients with type 2 diabetes and diabetic kidney disease.
How to Use / Dosage
Your doctor determines your dose based on kidney function, blood sugar goals, and other health conditions — never adjust your dose without medical guidance.
Timing: Typically taken once daily, before the first meal of the day.
Missed Dose: If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose — in that case, skip it and resume your normal schedule. Do not double up.
Do Not Stop Suddenly: Stopping canagliflozin without medical guidance can cause blood sugar to rise and may affect ongoing cardiovascular or kidney protection. Discuss any changes with your doctor first.
Side Effects
Most people tolerate canagliflozin well when taken as directed and monitored by their care team.
Common side effects may include genital yeast infections, urinary tract infections, increased urination, and thirst, related to the medication's glucose-elimination mechanism.
Serious side effects can include dehydration, low blood pressure, ketoacidosis (a serious buildup of blood acids), kidney problems, and an increased risk of lower-limb complications in some patients.
Emergency Warning Signs — seek medical care immediately if you experience:
Nausea, vomiting, abdominal pain, or unusual fatigue (possible signs of ketoacidosis)
Signs of dehydration such as dizziness or fainting, especially when standing
New pain, tenderness, sores, ulcers, or infection in the legs or feet
Signs of a urinary tract or genital infection, including pain, burning, or fever
Sudden decrease in urination or swelling (possible kidney issue)
Signs of an allergic reaction, such as rash, swelling, or difficulty breathing
Warnings & Precautions
Canagliflozin should be used cautiously in patients with reduced kidney function, as effectiveness and safety depend on adequate kidney function, and your doctor will check kidney function before and during treatment. Patients prone to volume depletion, older adults, and those on diuretics are at higher risk for dehydration and low blood pressure and should be monitored closely.
Regarding lower-limb complications, an FDA boxed warning about amputation risk was added in 2017, based on clinical trial data showing an approximate doubling of leg and foot amputation risk compared to placebo. That boxed warning was later removed in 2020 after newer clinical trial data showed the risk was lower than previously described, particularly with appropriate monitoring, and additional heart and kidney benefits were confirmed. The amputation risk is still discussed in the warnings and precautions section of current labeling, and patients should be monitored for new sores, ulcers, or infections in their lower limbs.
Drug interactions are an important safety consideration. Canagliflozin can interact with insulin, sulfonylureas, and other blood sugar-lowering medications, increasing the risk of low blood sugar (hypoglycemia); dose adjustments of other diabetes medications may be needed. It may also interact with diuretics, raising dehydration risk, and with certain enzyme-inducing drugs that can reduce its effectiveness.
Regarding pregnancy and breastfeeding, canagliflozin is not recommended during pregnancy, particularly in the second and third trimesters, and is not recommended while breastfeeding due to potential effects on kidney development in the infant. Safety and effectiveness in pediatric patients have not been established. Older adults may be more susceptible to volume depletion and should be monitored closely.
Who Should Not Use This Medication
Patients with severe kidney impairment or on dialysis
Patients with a history of diabetic ketoacidosis
Patients with type 1 diabetes (not approved for this use)
Patients with a known hypersensitivity to canagliflozin or its ingredients
Patients who are pregnant or breastfeeding, without physician guidance
Patients not under regular medical monitoring
Storage Instructions
Store at room temperature, away from excess heat, light, and moisture. Do not store in the bathroom. Keep out of reach of children and pets. Dispose of expired or unused medication properly rather than flushing it, unless specifically instructed to do so.
Frequently Asked Questions
Why does Canagliflozin 100 mg cause amputations?
Clinical trial data showed leg and foot amputation risk was roughly doubled with canagliflozin versus placebo in earlier studies. Later trials found this risk to be lower than initially reported, especially with proper monitoring, which is why patients should report any new foot sores, pain, or infection promptly.
What does Canagliflozin 100 mg do?
Canagliflozin lowers blood sugar by causing the kidneys to remove excess glucose through urine. It also helps reduce cardiovascular and kidney complication risks in certain adults with type 2 diabetes, when used alongside diet, exercise, and medical monitoring.
Are Canagliflozin reviews generally positive?
Many patients and prescribers report effective blood sugar control along with added heart and kidney benefits. Individual experiences vary based on health history, so discuss what to expect with your doctor rather than relying solely on reviews.
Does Canagliflozin 100 mg require a prescription?
Yes, canagliflozin is a prescription-only medication in the U.S. A doctor must evaluate your kidney function, diabetes history, and other health factors before prescribing it.
Is there a discount available for Canagliflozin 100 mg?
Generic canagliflozin may be more affordable than brand-name versions; check with your pharmacy, insurer, or manufacturer savings programs for current options. Exact pricing varies by location and coverage.
Where can I buy Canagliflozin 100mg online?
A valid prescription is required to buy Canagliflozin 100mg online. Your doctor can send the prescription electronically to a licensed pharmacy, which will verify it before dispensing and shipping your medication. Always choose a pharmacy verified through your state board of pharmacy or the NABP's Safe.
How long does it take for Canagliflozin to work?
Canagliflozin begins lowering blood sugar within the first few doses, but full effects on blood sugar control are typically assessed over several weeks. Your doctor will monitor lab results to confirm effectiveness and adjust treatment as needed.
References
FDA — MedWatch Safety Alert, Boxed Warning Removal for Canagliflozin: https://www.fda.gov/safety/medical-product-safety-information/invokana-invokamet-invokamet-xr-canagliflozin-medwatch-safety-alert-boxed-warning-about-risk-leg-and
FDA Drug Safety Podcast — Canagliflozin Boxed Warning Removal: https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-removes-boxed-warning-about-risk-leg-and-foot-amputations-diabetes-medicine-canagliflozin
University of Utah Health Pharmacy Services — Canagliflozin Products and Risk of Lower Limb Amputations: https://pharmacyservices.utah.edu/alerts/2020/08/canagliflozin-products-invokana-invokamet-invokamet-xr-and-risk-of-lower-limb
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified specialist or physician before using Canagliflozin 100 mg.
